Zealand Pharma Receives Milestone Payment from Helsinn Healthcare
9 December 2010 | By M:Communications
Zealand Pharma, today announces the receipt of a EUR 500,000 milestone payment as part of its license agreement with Helsinn Healthcare...
List view / Grid view
News
Point-of-care cardiac assays shorten turnaround times in emergency departments
8 December 2010 | By kdm communications limited
Radiometer, has used its expertise in acute clinical testing to develop a compact and cost-effective immunoassay analyser for measuring critical biomarkers at the patient’s bedside.
ERT Facilitates Global Growth with Appointment of Klaus Besier to Board of Directors
8 December 2010 | By The Scott Partnership
ERT, announced the appointment of Klaus Besier to the Company’s Board of Directors...
bioMérieux’s BioBall® Mixed Kits Provide Flexibility for the Pharmaceutical Industry
7 December 2010 | By bioMérieux
BioBall® is a small water soluble ball containing a precise number of micro-organisms delivering unprecedented accuracy...
European Commission Approves Brilique™ (Ticagrelor Tablets)
6 December 2010 | By AstraZeneca
AstraZeneca announced today that the European Commission has granted marketing authorisation to BRILIQUE™ (ticagrelor tablets)...
Phase II study with first-in-class investigational drug demonstrates improvement in negative symptoms in patients with schizophrenia
6 December 2010 | By F. Hoffmann-La Roche Ltd
Roche today presented eight-week results from a phase II study of RG16781...
e-Therapeutics plc Board appoints Stephen Self to direct development
6 December 2010 | By M:Communications
e-Therapeutics plc, announced that Steve Self, Development Director, has agreed to join the Board as an Executive Director with immediate effect...
Longer-term Phase III data show Novartis drug Tasigna® continues to surpass Glivec® in slowing disease progression in patients
6 December 2010 | By Novartis
with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)...
William Vickery joins Hybrigenics as Head of Corporate and Business Development
6 December 2010 | By ANDREW LLOYD & ASSOCIATES
Hybrigenics, today announces it has hired William Vickery as Head of Corporate and Business Development, a newly created position...
Tecan’s HydroFlex™ improves plate washing for ELISpot assays
2 December 2010 | By kdm communications limited
Tecan’s HydroFlex microplate washer has allowed hematologists at the University of Modena & Reggio Emilia, to introduce automated washing for Enzyme-Linked ImmunoSpot assays...
US FDA Advisory Committee Makes Recommendation on New Drug Application for Vandetanib in Advanced Medullary Thyroid Cancer
2 December 2010 | By AstraZeneca
AstraZeneca announced the outcome of the US FDA Advisory Committee meeting...
The Scott Partnership Expands Life Sciences Client Base with new Client, Prism Ideas
2 December 2010 | By The Scott Partnership
The Scott Partnership has been appointed by Prism Ideas, ato lead the company's new international PR campaign...
Janssen Announces Collaboration to Develop Diagnostic Biosignatures for Pre-Symptomatic Identification of Alzheimer’s Disease
1 December 2010 | By Johnson & Johnson
Janssen announced a research agreement to collaborate with GE Healthcare...
Chris Beaver joins PharmaNet as Director, Immunochemistry Services
29 November 2010 | By The Scott Partnership
PharmaNet Development Group, Inc., announces that Chris Beaver, PhD has joined the Company as Director, Immunochemistry Services...
GlaxoSmithKline to increase its shareholding in Theravance
29 November 2010 | By GlaxoSmithKline
GlaxoSmithKline and Theravance, Inc. announced today that GSK will increase its shareholding in Theravance through the purchase of Theravance common stock in a private placement...
